By Melissa Lipman (January 10, 2018, 2:04 PM EST) -- More than four years after the U.S. Supreme Court's landmark pay-for-delay ruling, Federal Trade Commission Chairman Maureen Ohlhausen indicated the antitrust enforcer's crackdown might have at last turned the corner as the number of potentially problematic pharmaceutical patent settlements dropped.
But litigation over past settlements continues to steam ahead in federal courts across the country.
Here's a cheat sheet of major pay-for-delay suits to watch in 2018.
Case: In re: Loestrin 24 Fe Antitrust Litigation
Court: District of Rhode Island
Drug: Loestrin, oral contraceptive
In this case, drug purchasers claim that Warner Chilcott PLC signed a series...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!